Gilead Sciences has announced positive topline results from the Phase 3 ARTISTRY-1 trial. The open-label trial evaluated the treatment responses of adults with HIV who ...
Ameren Illinois has reduced natural gas prices by 30% over the last five years and is offering tips to help customers save ...
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today reported financial ...
The economic consequences are staggering. Formerly incarcerated individuals face a 51.7 percent wage penalty, costing the U.S ...
It can be tough to find a good gift for tech obsessives. Since they keep up with the latest releases, they probably already ...
NEW YORK (AP) — It’s the most wonderful time of the year, unless you want to find the perfect gifts for tech lovers.
Heretic, debater, wife-snatcher, subject of a posthumous cult: Pico della Mirandola certainly had a wild career. In this smart and rangy book, Wilson-Lee, a Cambridge don, paints a glorious portrait ...
Google Trends over five years shows that interest in the drug in India has nearly doubled and remains high. Telangana ranks tenth, while Karnataka ranks higher. Hyderabad falls neatly within ...
As Gen Alpha grows up with AI, gaming, and social media, the next wave of marketing isn’t about selling to children but ...
The ARTISTRY-1 Phase III trial demonstrated that a single-tablet regimen of bictegravir 75 mg/lenacapavir 50 mg maintains viral suppression and simplifies therapy for people living with HIV, ...
Sadler, who has served as SCOA’s executive director since 2019, announced she will leave her position on June 30, 2026, after ...
Gilead Sciences, Inc. today announced positive topline results from the Phase 3 ARTISTRY-1 trial. The open-label trial evaluated the treatment responses of adults with HIV who are virologically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results